ATH 33.3% 0.4¢ alterity therapeutics limited

ongoing placement - ongoing dampening, page-15

  1. 221 Posts.
    lightbulb Created with Sketch. 90
    Can see this ongoing placement from both sides.

    Company wants to ensure it has plenty of cash to continue if results dont go well.

    As a shareholder I've purchased with the risk of a bad result and upside from a successful. I dont like the upside being dampened by continual placements. Why would an institution by on-market when it can go to the company (or its broker) and get a swag at just below the market price?

    Would rather that if the company sees the need to have a certain amount of cash on hand before trial results then it approaches all shareholders with an offer (as it did earlier in the year) and then get on with it.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $34 10K

Buyers (Bids)

No. Vol. Price($)
28 17196248 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130790145 27
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.